Holdings of Versant Venture Management, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 6 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Monte Rosa Therapeutics Inc | 3,180,780 | 52.3M $ | |
| 2 | Century Therapeutics Inc | 12,166,109 | 27.5M $ | |
| 3 | LENZ Therapeutics Inc | 2,656,888 | 24.3M $ | |
| 4 | JADE BIOSCIENCES INC | 1,525,820 | 21.4M $ | |
| 5 | Contineum Therapeutics Inc | 542,628 | 7.1M $ | |
| 6 | SKYE BIOSCIENCE INC | 2,007,704 | 1.2M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 6 | 133.9M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Versant Venture Management, LLC". https://titelia.com/en/funds/US13F1560009